TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: PROVEN: Pragmatic Trial of Video Education in Nursing Homes
Brief Summary: This is a pragmatic cluster-randomized control trial (RCT) of an Advance Care Planning (ACP) Video Program for nursing home (NH) patients ≥ 65 years old who are cared for in 360 NH facilities (intervention arm n=119; control arm n=241) within two NH health care systems: Genesis HealthCare and PruittHealth. The intervention NH facilities will implement the ACP Video Program, while the control NH facilities will follow their usual ACP procedures. The trial will evaluate the effectiveness of the ACP Video Program by comparing hospitalizations, advance directives, and hospice use in the intervention vs. control NHs.


Options:
A: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Risperidone, Drug: Escitalopram, Drug: Citalopram, Drug: Sertraline, Drug: Paroxetine | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Sertraline; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Paroxetine; Assigned to Arm(s): A
B: Intervention Type: DRUG; Name: galantamine hydrobromide; Assigned to Arm(s): N/A
C: Arm Label: Advance care planning intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Advance care planning intervention | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Control group | Intervention Type: BEHAVIORAL; Name: Advance care planning intervention; Assigned to Arm(s): Advance care planning intervention | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Usual care
D: Arm Label: ACP Video Program; Type: EXPERIMENTAL; Interventions: Behavioral: ACP Video Program | Arm Label: Usual ACP procedures; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ACP Video Program; Assigned to Arm(s): ACP Video Program

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Brief Summary: Scheduled, low-dose quetiapine is effective in preventing delirium in high-risk critically ill, trauma/surgical patients. Prophylaxis also reduced ventilator duration and ICU length of stay.


Options:
A: N/A
B: Intervention Type: DRUG; Name: Arsenic trioxide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Trisenox; Assigned to Arm(s): N/A
C: Arm Label: delirious patients; Type: N/A; Interventions: N/A | Arm Label: non-delirious patients; Type: N/A; Interventions: N/A
D: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Quetiapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Quetiapine | Intervention Type: DRUG; Name: Quetiapine; Assigned to Arm(s): Quetiapine

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RELAX: A Mobile Application Suite Targeting Obesity and Stress
Brief Summary: This research is being done is to evaluate the feasibility and acceptability of a novel weight loss mobile app that was designed to be less burdensome than traditional weight loss apps.


Options:
A: Arm Label: Comprehensive Dietary Self-Monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Comprehensive Dietary Self-Monitoring; Device: smartphone; Other: physical activity | Arm Label: Simple Dietary Self-Monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Simple Dietary Self-Monitoring; Device: smartphone; Other: physical activity | Intervention Type: BEHAVIORAL; Name: Comprehensive Dietary Self-Monitoring; Device: smartphone; Other: physical activity; Assigned to Arm(s): Comprehensive Dietary Self-Monitoring | Intervention Type: BEHAVIORAL; Name: Simple Dietary Self-Monitoring; Device: smartphone; Other: physical activity; Assigned to Arm(s): Simple Dietary Self-Monitoring
B: Arm Label: Theory-based podcast; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Podcast + mobile diet app | Arm Label: Theory-based podcast + Social POD; Type: EXPERIMENTAL; Interventions: Behavioral: Podcast + theory-based mobile diet app | Intervention Type: BEHAVIORAL; Name: Podcast + mobile diet app; Assigned to Arm(s): Theory-based podcast | Intervention Type: BEHAVIORAL; Name: Podcast + theory-based mobile diet app; Assigned to Arm(s): Theory-based podcast + Social POD
C: Arm Label: Simple; Type: EXPERIMENTAL; Interventions: Behavioral: Simple | Arm Label: Standard; Type: EXPERIMENTAL; Interventions: Behavioral: Standard | Intervention Type: BEHAVIORAL; Name: Simple; Assigned to Arm(s): Simple | Intervention Type: BEHAVIORAL; Name: Standard; Assigned to Arm(s): Standard
D: Arm Label: RIDE; Type: EXPERIMENTAL; Interventions: Behavioral: RIDE e-health application | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: RIDE e-health application; Assigned to Arm(s): RIDE

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Feasibility of Melatonin for Prevention of Delirium in Critically Ill Patients: a Multi-centre, Randomized, Placebo-controlled Study.
Brief Summary: The purpose of this study is to determine the feasibility of conducting a randomized controlled trial (RCT) with melatonin for prevention of delirium in critically ill adult patients. The investigators hypothesize that melatonin, administered on a scheduled nightly basis during ICU admission, will be efficacious and safe for the prevention of delirium in critically ill adults.


Options:
A: Arm Label: dexmedetomidine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexmedetomidine | Arm Label: propofol group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): dexmedetomidine group
B: Arm Label: Enteral melatonin 0.5 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Melatonin | Arm Label: Enteral melatonin 2 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Melatonin | Arm Label: Enteral matched placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Melatonin; Assigned to Arm(s): Enteral melatonin 0.5 mg, Enteral melatonin 2 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Enteral matched placebo
C: Intervention Type: DRUG; Name: Arsenic trioxide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Trisenox; Assigned to Arm(s): N/A
D: Arm Label: Non-sedation; Type: EXPERIMENTAL; Interventions: Other: Non-sedation | Arm Label: Sedation; Type: ACTIVE_COMPARATOR; Interventions: Other: Control: Sedation | Intervention Type: OTHER; Name: Non-sedation; Assigned to Arm(s): Non-sedation | Intervention Type: OTHER; Name: Control: Sedation; Assigned to Arm(s): Sedation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: With the dissatisfaction of monoamine-based pharmacotherapy and the high comorbidity of physical illness in depression, the serotonin hypothesis seems to fail in approaching the etiology of depression. Based upon the evidence from epidemiological data, case-control studies of PUFAs compositions, and antidepressant effects in clinical trials, phospholipid polyunsaturated fatty acids (PUFAs) is enlightening a promising path to discover the unsolved of depression.


Options:
A: Arm Label: Soybean oil soft gels; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Soybean oil soft gels | Arm Label: Fish oil omega-3 EPA-rich soft gels; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Fish oil omega-3 EPA-rich soft gels | Intervention Type: DIETARY_SUPPLEMENT; Name: Soybean oil soft gels; Assigned to Arm(s): Soybean oil soft gels | Intervention Type: DIETARY_SUPPLEMENT; Name: Fish oil omega-3 EPA-rich soft gels; Assigned to Arm(s): Fish oil omega-3 EPA-rich soft gels
B: Arm Label: EPA; Type: EXPERIMENTAL; Interventions: Dietary Supplement: EPA | Arm Label: DHA; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: DHA | Arm Label: Placebo capsules; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: EPA; Assigned to Arm(s): EPA | Intervention Type: DIETARY_SUPPLEMENT; Name: DHA; Assigned to Arm(s): DHA | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo capsules
C: Arm Label: EPA 3.5 g/day; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Omega-3 fatty acids | Arm Label: Placebo capsules; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Omega-3 fatty acids | Arm Label: DHA 1.75 g/day; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Omega-3 fatty acids | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 fatty acids; Assigned to Arm(s): DHA 1.75 g/day, EPA 3.5 g/day, Placebo capsules
D: Arm Label: Infliximab; Type: EXPERIMENTAL; Interventions: Drug: Infliximab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Infliximab; Assigned to Arm(s): Infliximab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect on Attendance if Including Focused Information of Spirometry in Preventive Health Checks - a Randomized Controlled Trial in Primary Health Care
Brief Summary: The purpose of this study is to investigate if focused information of spirometry in the invitation to preventive health checks will increase the attendance compared with a standard invitation to preventive health checks.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Procedure: optimised treatment | Intervention Type: PROCEDURE; Name: optimised treatment; Assigned to Arm(s): Intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm; Assigned to Arm(s): 1
C: Arm Label: Invitation with focused information of spirometry; Type: EXPERIMENTAL; Interventions: Behavioral: focused information of spirometry in the invitation | Arm Label: Standard invitition; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: standard invitation | Intervention Type: BEHAVIORAL; Name: focused information of spirometry in the invitation; Assigned to Arm(s): Invitation with focused information of spirometry | Intervention Type: BEHAVIORAL; Name: standard invitation; Assigned to Arm(s): Standard invitition
D: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Life style Intervention and care coordination; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated cardiovascular disease risk management. | Intervention Type: BEHAVIORAL; Name: Integrated cardiovascular disease risk management.; Assigned to Arm(s): Life style Intervention and care coordination

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Monitoring Adherence Using Mobile Technology
Brief Summary: This study plans to learn more about how children use their asthma medicines. The investigators would like to see if special electronic monitoring devices that connect to smartphones and computers can help children to better manage their asthma


Options:
A: Arm Label: Intervention; Type: N/A; Interventions: Device: Propeller Health Monitoring Device | Intervention Type: DEVICE; Name: Propeller Health Monitoring Device; Assigned to Arm(s): Intervention
B: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text Messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Text Messaging | Intervention Type: BEHAVIORAL; Name: Text Messaging; Assigned to Arm(s): Text Messaging
C: Arm Label: Active Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Feedback | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Active Feedback | Intervention Type: BEHAVIORAL; Name: Active Feedback; Assigned to Arm(s): Active Feedback, Control
D: Arm Label: Asthma Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Asthma Feedback | Arm Label: Preventive Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Asthma Feedback | Intervention Type: BEHAVIORAL; Name: Asthma Feedback; Assigned to Arm(s): Asthma Feedback, Preventive Feedback

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Telemedical Support for Prehospital Emergency Medical Service - a Prospective Randomized Controlled Trial
Brief Summary: The purpose of this study is to evaluate the safety and quality of a pre-hospital holistic multifunctional teleconsultation system. This system consists of on-line transmissions of vital parameters, audio- and video-signals from the scene to a telemedicine centre, where a trained emergency physician (tele-EMS physician) uses software-based guideline conform algorithms for diagnosis and treatment.

At the prehospital emergency scene half of the patients will receive this telemedicine-based approach and the other half the conventional emergency physician-based care.


Options:
A: Arm Label: Conventional EMS physician; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional EMS physician | Arm Label: Tele-EMS physician; Type: OTHER; Interventions: Other: tele-EMS physician | Intervention Type: OTHER; Name: conventional EMS physician; Assigned to Arm(s): Conventional EMS physician | Intervention Type: OTHER; Name: tele-EMS physician; Assigned to Arm(s): Tele-EMS physician
B: Arm Label: Standard consultation; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care in orthopaedic outpatient clinic | Arm Label: Telemedicine consultation; Type: EXPERIMENTAL; Interventions: Other: Telemedicine consultation | Intervention Type: OTHER; Name: Telemedicine consultation; Assigned to Arm(s): Telemedicine consultation | Intervention Type: OTHER; Name: Standard care in orthopaedic outpatient clinic; Assigned to Arm(s): Standard consultation
C: Arm Label: Usual care (UC); Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Arm Label: Self-management; Type: EXPERIMENTAL; Interventions: Device: Self-management | Arm Label: PCTM intervention; Type: EXPERIMENTAL; Interventions: Other: PCTM intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care (UC) | Intervention Type: DEVICE; Name: Self-management; Assigned to Arm(s): Self-management | Intervention Type: OTHER; Name: PCTM intervention; Assigned to Arm(s): PCTM intervention
D: Arm Label: Experimental; Type: N/A; Interventions: Other: CAPRI | Arm Label: Control; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: CAPRI; Assigned to Arm(s): Experimental

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 1B Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
Brief Summary: A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis.


Options:
A: Arm Label: Antibiotics in addition to steroids; Type: EXPERIMENTAL; Interventions: Drug: AB (antibiotics) | Arm Label: Steroids only; Type: ACTIVE_COMPARATOR; Interventions: Drug: CS (corticosteroids) Only | Arm Label: Open arm; Type: OTHER; Interventions: Drug: AB (antibiotics), Drug: CS (corticosteroids) Only | Intervention Type: DRUG; Name: AB (antibiotics); Assigned to Arm(s): Antibiotics in addition to steroids, Open arm | Intervention Type: DRUG; Name: CS (corticosteroids) Only; Assigned to Arm(s): Open arm, Steroids only
B: Arm Label: Weekly SER-287, after Placebo Pre-Treat.; Type: EXPERIMENTAL; Interventions: Drug: SER-287, Drug: Placebo Pre-Treat | Arm Label: Daily placebo, after Placebo Pre-Treat.; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Placebo Pre-Treat | Arm Label: Daily SER-287, after Vanco. Pre-Treat.; Type: EXPERIMENTAL; Interventions: Drug: SER-287, Drug: Vancomycin Pre-Treat | Arm Label: Weekly SER-287, after Vanco. Pre-Treat.; Type: EXPERIMENTAL; Interventions: Drug: SER-287, Drug: Vancomycin Pre-Treat | Intervention Type: DRUG; Name: SER-287; Assigned to Arm(s): Daily SER-287, after Vanco. Pre-Treat., Weekly SER-287, after Placebo Pre-Treat., Weekly SER-287, after Vanco. Pre-Treat. | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Daily placebo, after Placebo Pre-Treat. | Intervention Type: DRUG; Name: Placebo Pre-Treat; Assigned to Arm(s): Daily placebo, after Placebo Pre-Treat., Weekly SER-287, after Placebo Pre-Treat. | Intervention Type: DRUG; Name: Vancomycin Pre-Treat; Assigned to Arm(s): Daily SER-287, after Vanco. Pre-Treat., Weekly SER-287, after Vanco. Pre-Treat.
C: Arm Label: Azithromycin + Metronidazole; Type: EXPERIMENTAL; Interventions: Drug: Azithromycin + Metronidazole | Arm Label: Metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metronidazole | Intervention Type: DRUG; Name: Azithromycin + Metronidazole; Assigned to Arm(s): Azithromycin + Metronidazole | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Metronidazole
D: Arm Label: Antibiotic; Type: EXPERIMENTAL; Interventions: Drug: Ceftriaxone, Drug: Metronidazole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo infusion | Intervention Type: DRUG; Name: Ceftriaxone; Assigned to Arm(s): Antibiotic | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Antibiotic | Intervention Type: OTHER; Name: Placebo infusion; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.
Brief Summary: Bronchiolitis in infants and young children often requires respiraty support. In Denmark Continous Positive Airway Pressure ( CPAP) are routinely used in children with moderate-severe bronchiolitis. The aim of the study is to compare CPAP and High Flow Oxygenation Therapy (HFOT) as tools of respiratory support in infants and young children with bronchiolitis.

Infants and young children with moderate-severe bronchiolitis and are randomized to either CPAP or HFOT.


Options:
A: Arm Label: High flow nasal cannula (HFNC); Type: EXPERIMENTAL; Interventions: Device: Treatment strategy: Non-invasive respiratory support delivered via high flow nasal cannula | Arm Label: Continuous positive airway pressure (CPAP); Type: ACTIVE_COMPARATOR; Interventions: Device: Treatment strategy: Non-invasive respiratory support delivered via continuous positive airway pressure | Intervention Type: DEVICE; Name: Treatment strategy: Non-invasive respiratory support delivered via high flow nasal cannula; Assigned to Arm(s): High flow nasal cannula (HFNC) | Intervention Type: DEVICE; Name: Treatment strategy: Non-invasive respiratory support delivered via continuous positive airway pressure; Assigned to Arm(s): Continuous positive airway pressure (CPAP)
B: Arm Label: High flows; Type: OTHER; Interventions: Device: Use of high flows versus oxygen therapy, Device: oxygen therapy | Arm Label: oxygen therapy; Type: OTHER; Interventions: Device: oxygen therapy | Intervention Type: DEVICE; Name: Use of high flows versus oxygen therapy; Assigned to Arm(s): High flows | Intervention Type: DEVICE; Name: oxygen therapy; Assigned to Arm(s): High flows, oxygen therapy
C: Arm Label: Continous Positive Airway Pressure; Type: ACTIVE_COMPARATOR; Interventions: Device: Continous Positive Airway Pressure | Arm Label: High Flow Oxygenation Therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Optiflow Junior | Intervention Type: DEVICE; Name: Optiflow Junior; Assigned to Arm(s): High Flow Oxygenation Therapy | Intervention Type: DEVICE; Name: Continous Positive Airway Pressure; Assigned to Arm(s): Continous Positive Airway Pressure
D: Arm Label: Group 1; Type: OTHER; Interventions: Device: High-Flow Nasal Oxygen / Non-invasive ventilation / Standard oxygen | Arm Label: Group 2; Type: OTHER; Interventions: Device: High-Flow Nasal Oxygen / Non-invasive ventilation / Standard oxygen | Intervention Type: DEVICE; Name: High-Flow Nasal Oxygen / Non-invasive ventilation / Standard oxygen; Assigned to Arm(s): Group 1, Group 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The aims of this study were to compare health related quality of life, comforts degrees，retention effectiveness, and failure rates as well as survival times between two clear overlay retainers with different thicknesses, thus to provide basis information regarding appropriate selections of the thickness of clear overlay retainers.


Options:
A: Arm Label: Conventional; Type: EXPERIMENTAL; Interventions: Device: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model | Arm Label: 3D; Type: EXPERIMENTAL; Interventions: Device: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model | Intervention Type: DEVICE; Name: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model; Assigned to Arm(s): 3D, Conventional
B: Arm Label: Thermoplastic Retainer; Type: EXPERIMENTAL; Interventions: Other: orthodontic appliance | Arm Label: Hawley Retainer; Type: ACTIVE_COMPARATOR; Interventions: Other: orthodontic appliance | Intervention Type: OTHER; Name: orthodontic appliance; Assigned to Arm(s): Hawley Retainer, Thermoplastic Retainer
C: Arm Label: retainer: 0.75-mm-thick film; Type: EXPERIMENTAL; Interventions: Device: retainer | Arm Label: retainer: 1.00-mm-thick film; Type: EXPERIMENTAL; Interventions: Device: retainer | Intervention Type: DEVICE; Name: retainer; Assigned to Arm(s): retainer: 0.75-mm-thick film, retainer: 1.00-mm-thick film
D: Arm Label: Fiber reinforced composite retainers; Type: EXPERIMENTAL; Interventions: Device: Orthodontic retainers | Arm Label: Multistranded stainless steel retainers; Type: EXPERIMENTAL; Interventions: Device: Orthodontic retainers | Intervention Type: DEVICE; Name: Orthodontic retainers; Assigned to Arm(s): Fiber reinforced composite retainers, Multistranded stainless steel retainers

Answer: C